Stocks-BLUE-Bluebird Bio Inc

BLUE Bluebird Bio Inc

1.03 0 (0%)
Mercado cerradoPrecios retrasados ofrecidos por el índice NASDAQ, en USD
Invertir

Precio de Bluebird Bio Inc

6.46% Semana pasada
Created with Highcharts 4.2.7 /Highstock 4.2.7
Capitalización de mercado
198.52M
Rango de días
1.00
-
1.05
Rango de 52S
0.8521
-
6.01
Volumen (3M)
12.54M
Relación precio/beneficio
-1.38
Ingresos
21.73M
Publicación incluida
Cancer Treatment Stocks
Novartis to acquire cancer-focused MorphoSys for $2.9 billion. 💊 Drugmaker $NVS (Novartis ADR) said it will acquire $MOR.DE (MorphoSys), a developer of cancer treatments, for €2.7 billion, adding a promising rare bone-marrow cancer treatment candidate to its portfolio. German biotech firm's shares... Mostrar más Traducir
Me gusta ComentarCompartir
Mostrar más comentarios2 de 3
null
.
Debates sobre Destacado
Claudiafarn
$BLUE (Bluebird Bio Inc) looks good to buy, but history of this stock is stoping me to buy Traducir
undefined logo
BLUE
Bluebird Bio Inc
1.00
0 (0.00%)
Invertir
Me gusta ComentarCompartir
null
.
Women-led Companies
Dear Investors, Here is your monthly update for December 2023 ✨ December concluded the year with impressive equity performances, marked by the reaching of all-time highs in major indices like the Dow Jones Industrial Average, Nasdaq-100, CAC 40, and DAX. Additionally, gold briefly surged to its highest... Mostrar más Traducir
Me gusta ComentarCompartir
null
.
IvanGarciaMillan
$BLUE (Bluebird Bio Inc) 🔝🔝🆙🆙🆙🔝🔝🔝🔝🆙🆙🆙
undefined logo
BLUE
Bluebird Bio Inc
1.00
0 (0.00%)
Invertir
Me gusta ComentarCompartir
null
.
IvanGarciaMillan
$BLUE (Bluebird Bio Inc) 🔝🔝🔝🔝🔝🔝🔝🔝🔝🔝🔝
undefined logo
BLUE
Bluebird Bio Inc
1.00
0 (0.00%)
Invertir
David Starlyte
$BLUE (Bluebird Bio Inc) in the RED! They recently received FDA-approval but $CRSP (CRISPR Therapeutics AG) and $VRTX (Vertex Pharmaceuticals Incorporated) also came out with a similar drug which doesnt have certain side effects compared with Bluebird. Far from its $115.36 high achieved in 2018. Bluebird... Mostrar más Traducir

Previsión de los analistas

Consenso
Mantenga
Precio objetivo
4.00

ESG: Una nueva fuente de conocimientos

Obtenga información sobre la sostenibilidad de una empresa mediante las puntuaciones de ESG (medioambiental, social y de gobernanza).
0
100
36
Muy bajo
Sector 
Promedio 43 
32
Medio ambiente
48
Social
24
Gobernanza

La gente también compró